Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.
about
Paclitaxel: new uses for an old drug.A chemical stability study of trimethylsilane plasma nanocoatings for coronary stentsCritical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentTargeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graftEnhancement of osteosarcoma cell sensitivity to cisplatin using paclitaxel in the presence of hyperthermia.Gold nanorods as a theranostic platform for in vitro and in vivo imaging and photothermal therapy of inflammatory macrophages.Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions.Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels.Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis.Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.Restenosis after PCI. Part 2: prevention and therapy.Below-the-knee drug-eluting stents and drug-coated balloons.Lesion complexity determines arterial drug distribution after local drug delivery.Vascular pathology as a result of drug-eluting stents.The effect of short-term intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local thrombotic environment after angioplasty.Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
P2860
Q27691306-24815E1B-8C06-4863-908C-EA4A1F4F789BQ28820958-DF5D9E87-EC33-47CC-88DA-7B8457CB45A5Q33710114-DF870180-C378-4C70-9B07-40A24524CD22Q34089207-313257B5-5F3B-4981-B070-E842E12D1E23Q34140175-D80746D3-9C3C-4A7B-BDAD-AB2B428FD729Q34635725-A9DB3E12-9FBA-4CF4-B32C-582356EAEC84Q35728244-512A9478-50C8-4C1D-B761-DA126AFEAB92Q36541536-20CF01A1-7AE1-4CF6-BF24-0C3C9068C946Q36707886-4065607D-E89E-484F-A352-EB0231FEB860Q37374015-3907715F-08FD-46D1-B6E4-4C0D9D3DA379Q37580863-19E7ED62-E751-4858-BA81-B8640D1641C0Q37944416-D45EB5F2-E2E4-422F-BCD1-2963B8B330EAQ37965246-D18C18A3-3F5A-4171-92BF-08CE10A1C8F1Q41415263-8ECD2C96-51FC-4A2E-A481-7800669D74B3Q42339589-DD386528-4270-47B1-BC17-F92BCB7DCA0EQ43588094-8BC5CFB4-C38D-435D-9CCC-D7EC3D7893DAQ52872863-B028525D-D24F-4CC5-B2AB-B1101489E090
P2860
Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sirolimus and paclitaxel provo ...... ying atherosclerotic arteries.
@en
type
label
Sirolimus and paclitaxel provo ...... ying atherosclerotic arteries.
@en
prefLabel
Sirolimus and paclitaxel provo ...... ying atherosclerotic arteries.
@en
P2093
P2860
P356
P1433
P1476
Sirolimus and paclitaxel provo ...... lying atherosclerotic arteries
@en
P2093
Daniel Eefting
J Wouter Jukema
Margreet R de Vries
P2860
P304
P356
10.1136/HRT.2006.102244
P407
P577
2007-04-20T00:00:00Z